Praxis Precision Medicines
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Praxis Precision Medicines 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PRAX
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus.
CEOMarcio Souza
CEOMarcio Souza
Employees168
Employees168
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2015
Founded2015
Employees168
Employees168
PRAX Key Statistics
Market cap9.81B
Market cap9.81B
Price-Earnings ratio-27.18
Price-Earnings ratio-27.18
Dividend yield—
Dividend yield—
Average volume291.76K
Average volume291.76K
High today$357.49
High today$357.49
Low today$349.82
Low today$349.82
Open price$352.48
Open price$352.48
Volume170.98K
Volume170.98K
52 Week high$392.70
52 Week high$392.70
52 Week low$37.19
52 Week low$37.19
Stock Snapshot
Praxis Precision Medicines(PRAX) stock is priced at $351.81, giving the company a market capitalization of 9.81B. It carries a P/E multiple of -27.18.
On 2026-09-05, Praxis Precision Medicines(PRAX) stock traded between a low of $349.82 and a high of $357.49. Shares are currently priced at $351.81, which is +0.6% above the low and -1.6% below the high.
The Praxis Precision Medicines(PRAX)'s current trading volume is 170.98K, compared to an average daily volume of 291.76K.
In the last year, Praxis Precision Medicines(PRAX) shares hit a 52-week high of $392.70 and a 52-week low of $37.19.
In the last year, Praxis Precision Medicines(PRAX) shares hit a 52-week high of $392.70 and a 52-week low of $37.19.
Analyst ratings
89%
of 19 ratingsBuy
89.5%
Hold
5.3%
Sell
5.3%
People also own
Based on the portfolios of people who own PRAX. This list is generated using Robinhood data, and it’s not a recommendation.